drugset / Trial / NCT00699153
Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
Evaluation of the clinical safety and efficacy of loteprednol etabonate in an ophthalmic base, when compared to vehicle for the treatment of inflammation following cataract surgery.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-05
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loteprednol Etabonate | Other / unclassified | 0.5 % | — |
Indications
No indication recorded.